University of Manitoba
Winnipeg, MB, Canada
Professor of Medicine in Rheumatology, research and clinical focus on SLE outcomes and health disparities
2588: Updated Analyses of Cancer Incidence and Risk Factors in a Large International SLE Cohort
Wednesday, November 15, 2023
11:15 AM – 11:25 AM PT
Disclosure(s): AstraZeneca: Consultant (Ongoing), Grant/Research Support (Ongoing); GlaxoSmithKlein(GSK): Consultant (Terminated, April 26, 2023); Roche: Advisor or Review Panel Member (Ongoing)